NCT06957054

Neural Biomarkers in Fragile X Syndrome

Assessment of Neural Biomarkers in Adult Subjects With Fragile X Syndrome and Typically Developing Subjects

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 20 (actual)
• Sponsor: Connecta Therapeutics, S.L. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this non-interventional test /re-test study is to assess neural biomarkers in adult subjects with Fragile X syndrome compared to those measured in a population of typically developing adults

Detailed description

This study consists of a screening period and two cross sectional evaluations assessed in one month interval (test/re-test), first on the Visit 1 (Basal) and the other on the Visit 2 (end-of-study visit, EOS).

Conditions

• Fragile X Syndrome (FXS)
• Neurotypical Adults

Interventions

Type	Name	Description
OTHER	Any	Any

Timeline

• Start date: 2024-12-16
• Primary completion: 2025-03-20
• Completion: 2025-03-20
• First posted: 2025-05-04
• Last updated: 2025-05-04

Locations

2 sites across 1 country: Spain